Article
Dual blockade of adenosine A2A and A 2B receptors is required to reverse NECA-induced immunosuppression in human macrophages: Implications for cancer immunotherapy
2025-09-09
Abstract excerpt
<title>Abstract</title> <p>Adenosine receptors are a target for cancer immunotherapy, with high levels of adenosine in the tumour microenvironment producing immunosuppressive effects. Most clinical trials in cancer are targeting the A<sub>2A</sub> adenosine receptor, but evidence suggests that both the A<sub>2A</sub> and A<sub>2B </sub>receptors are important for determining the effect of adenosine in myeloid-lin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aa2423ac-2792-5200-8f2c-4e314cad8cf4
- DOI
- 10.21203/rs.3.rs-6975438/v1
